Site reversion in cardiac rhythm management

• US 20030176894A1
• Filed: 12/09/2002
• Published: 09/18/2003
• Est. Priority Date: 08/30/2000
• Status: Active Grant

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Stahmann, Jeffrey E., Kramer, Andrew P.
• Granted Patent: US 6,922,589 B2
• Time in Patent Office: Days
• US Class Current: 607/9
• CPC Class Codes: A61N 1/3603 Control systems
• CPC Class Codes: A61N 1/3627 for treating a mechanical deficiency of the heart, e.g. congestive heart failure or cardiomyopathy
• CPC Class Codes: A61N 1/3706 Pacemaker parameters stimulation threshold A61N1/371

Abstract

Methods for failure recovery in a cardiac rhythm management system and apparatus capable of carrying out the methods. The methods include applying a first pacing therapy using one or more leads. The methods further include detecting a failure condition on one or more of the leads, wherein the failure condition prohibits or frustrates application of the first pacing therapy. The methods still further include applying a second pacing therapy using one or more of the leads subsequent to detecting the failure condition. The second pacing therapy is preferably chosen such that the detected failure does not interfere with the second pacing therapy. The second pacing therapy may be applied for only one cardiac cycle. The second pacing therapy may further be applied continuously until the failure condition is resolved, or it may be latched such that physician intervention is required to resume the first pacing therapy.

Claims

1. A cardiac rhythm management system, comprising:

a signal generator;

a first electrode adapted for connection to the signal generator;

a second electrode adapted for connection to the signal generator; and

a processor coupled to the signal generator, wherein the processor is adapted to cause the signal generator to deliver a first therapy to the first electrode, and to deliver a second therapy to the second electrode in the presence of a failure associated with the first electrode.

2. The cardiac rhythm management system of claim 1, wherein delivering the first therapy to the first electrode includes delivering the first therapy to both the first and second electrodes.

3. The cardiac rhythm management system of claim 2, wherein delivering the first therapy to the first and second electrodes includes delivering a first pulse to the first electrode and a second pulse to the second electrode.

4. The cardiac rhythm management system of claim 1, wherein the pulses applied to the second electrode in the second therapy are substantially similar to the pulses applied to the first electrode in the first therapy.

5. The cardiac rhythm management system of claim 1, wherein the first electrode is adapted to operate in at least one mode selected from the group consisting of bipolar and unipolar, and wherein the processor is further adapted to cause the signal generator to deliver the second therapy only when the first electrode is operating in the unipolar mode.

6. The cardiac rhythm management system of claim 1, wherein the presence of a failure is indicated by detection of a condition selected from the group consisting of an over sense condition, sensed noise, lead impedance outside a predetermined range, capture amplitude voltage outside a predetermined range, intrinsic amplitude outside a predetermined range, detection of unintended non-cardiac stimulation, and failure to detect an expected event.

7. The cardiac rhythm management system of claim 1, wherein the presence of a failure is indicated by detection of a condition selected from the group consisting of an electrical hardware failure, software failure, memory failure and battery depletion.

8. The cardiac rhythm management system of claim 1, including a lead adapted for connection to the signal generator, the lead comprising a main lead body adapted to carry signals to and from the heart, where the first electrode and the second electrode are carried by the main lead body.

9. A cardiac rhythm management system, comprising:

a first lead having at least one electrode;

a second lead having at least one electrode;

a signal generator for producing pulses to apply through the first and second leads; and

a processor coupled to the signal generator, wherein the processor is adapted to cause the signal generator to deliver a first therapy through the at least one electrode of the first lead and to deliver a second therapy through the at least one electrode of the second lead in the presence of a failure detection associated with the first lead.

10. The cardiac rhythm management system of claim 9, wherein delivering the first therapy to the at least one electrode of the first lead includes delivering the first therapy to the at least one electrodes of both the first and second leads.

11. The cardiac rhythm management system of claim 10, wherein delivering the first therapy to the at least one electrodes of the first and second leads includes delivering a first pulse to the at least one electrode on the first lead and a second pulse to the at least one electrode on the second lead.

12. The cardiac rhythm management system of claim 9, wherein the first and second therapy includes pulses, where pulses of the first therapy are substantially similar to pulses of the second therapy.

13. The cardiac rhythm management system of claim 9, wherein the at least one electrode of the first lead is adapted to operate in at least one mode selected from the group consisting of bipolar and unipolar, and wherein the processor is further adapted to cause the signal generator to deliver the second therapy only when the at least one electrode of the first lead is operating in the unipolar mode.

14. The cardiac rhythm management system of claim 9, wherein the presence of a failure is indicated by detection of a condition selected from the group consisting of an over sense condition, sensed noise, lead impedance outside a predetermined range, capture amplitude voltage outside a predetermined range, intrinsic amplitude outside a predetermined range, detection of unintended non-cardiac stimulation, and failure to detect an expected event.

15. The cardiac rhythm management system of claim 9, wherein the presence of a failure is indicated by detection of a condition selected from the group consisting of an electrical hardware failure, software failure, memory failure and battery depletion.

16. A method, comprising:

delivering a first therapy through a first electrode and a second electrode;

detecting a failure associated with the first electrode;

discontinuing the first therapy; and

delivering a second therapy to the second electrode.

17. The method of claim 16, wherein discontinuing the first therapy includes discontinuing the first therapy during the failure associated with the first electrode, and where delivering the second therapy includes delivering the second therapy to the second electrode during the failure associated with the first electrode.

18. The method of claim 16, including operating the first electrode in at least one mode selected from the group consisting of bipolar and unipolar, and wherein delivering the second therapy to the second electrode only occurs when the first electrode is operating in the unipolar mode.

19. The method of claim 16, wherein detecting a failure associated with the first electrode includes detecting a condition selected from the group consisting of an over-sense condition, sensed noise, lead impedance outside a predetermined range, capture amplitude voltage outside a predetermined range, intrinsic amplitude outside a predetermined range, detection of unintended non-cardiac stimulation, and failure to detect an expected event.

20. A method, comprising:

delivering a first therapy through a first lead having at least one electrode;

detecting a failure associated with the first lead;

discontinuing the first therapy; and

delivering a second therapy to a second lead having at least one electrode.

21. The method of claim 20, wherein discontinuing the first therapy includes discontinuing the first therapy during the failure associated with the first lead, and where delivering the second therapy includes delivering the second therapy to the second electrode during the failure associated with the first lead.

22. The method of claim 20, including operating the at least one electrode of the first lead in at least one mode selected from the group consisting of bipolar and unipolar, and wherein delivering the second therapy to the at least one electrode of the second lead only occurs when the at least one electrode of the first lead is operating in the unipolar mode.

23. The method of claim 20, wherein detecting a failure associated with the first lead includes detecting a condition selected from the group consisting of an over sense condition, sensed noise, lead impedance outside a predetermined range, capture amplitude voltage outside a predetermined range, intrinsic amplitude outside a predetermined range, detection of unintended non-cardiac stimulation, and failure to detect an expected event.

24. The method of claim 20, wherein detecting a failure associated with the first lead includes detecting a condition selected from the group consisting of an electrical hardware failure, software failure, memory failure and battery depletion.